EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Genetic Testing for Children with Familial Hypercholesterolemia

Keiko Nagahara, Hayato Tada, Kazushige Dobashi

Journal of Atherosclerosis and Thrombosis · 01.03.2026 · 33 (3) · 237-248

DOI: 10.5551/jat.rv22046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.03.2026. Verfasst von Keiko Nagahara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Showa Medical University School of Medicine. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Genetic Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia (FH) is a highly prevalent genetic disorder that occurs in approximately one in 300 people in the general population. In cases of heterozygous FH, which are encountered frequently, cardiovascular disease, the main complication, typically manifests after adulthood. However, if the diagnosis and treatment begin in childhood, the onset of such complications can be prevented. Therefore, it can be said that the diagnosis and treatment of this disease from childhood is extremely important; even more so in the case of homozygous FH. However, specific indicators for diagnosing FH physical findings such as Achilles tendon thickening and tendon xanthomas rarely manifest in childhood. It is also difficult to obtain detailed medical histories from relatives. Therefore, it is not always easy to make a clinical diagnosis. In this context, since 2022, genetic testing for FH has been covered by national health insurance in Japan, and it can be considered for children as needed. This paper presents the previous research concerning genetic testing for children, its importance and application, as well as the latest findings on universal screening that includes genetic testing. It is expected that the development of pediatric FH management in our country, which has not been particularly proactive until now, will contribute to the suppression of cardiovascular complications in this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIGenetic TestingHumansChildJapan

Stichwörter der Autor:innen

ChildrenFHGeneLDL-CholesterolLDLR

Autor:innen und Institutionen

  • Department of Pediatrics, Showa Medical University School of Medicine.
  • Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine.
  • Department of Pediatrics, School of Medicine, University of Yamanashi.

Zitieren

APA

Nagahara, K., Tada, H., & Dobashi, K. (2026). Genetic Testing for Children with Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis, 33(3), 237-248. https://doi.org/10.5551/jat.rv22046

Vancouver

Nagahara K, Tada H, Dobashi K. Genetic Testing for Children with Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 2026;33(3):237-248. doi:10.5551/jat.rv22046

BibTeX
@article{Nagahara2026,
  author = {Nagahara, Keiko and Tada, Hayato and Dobashi, Kazushige},
  title = {Genetic Testing for Children with Familial Hypercholesterolemia},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {237--248},
  doi = {10.5551/jat.rv22046}
}
Kostenlos starten →